1 Planet Pharma to Launch Cannabis Futures Commoditization Plan in Colombia

[ad_1]

1 Planet Pharma Announces Planned Launch of Commodity-Primarily based Cannabis Futures Plan Developed to Deliver Components to Item Makers

Las Vegas, Nevada–(Newsfile Corp. – October 31, 2019) – 1 Planet Pharma Inc. (OTC Pink: OWPC), “OWP,” a completely licensed pure-play cannabis and hemp ingredient producer in Colombia, currently announced the upcoming launch of the cannabis industry’s very first ‘Cannabis Futures’ system at their increasing operations in Colombia. OWP’s system is developed to assistance and fuel projected international cannabis sector development by permitting makers to repair their cost in advance for cannabis and hemp derived components made by OWP at space especially allocated to every single distinct manufacturer at OWP’s cultivation facilities in Colombia. The commoditized method to sourcing hemp and cannabis components anticipates and recognizes the organic maturity of the legal cannabis market place and gives makers of customer-packaged goods (CPG) an effortless way to enter the cannabis merchandise market place with a constant provide of components and predictable pricing.

With the cannabis sector predicted to continue to swiftly expand, scalability is an crucial in cannabis. 1 Planet Pharma believes that the future of cannabis is as a commodity, related to coffee beans or orange juice exactly where best components are grown and sold to important customer brands. Even though other cannabis providers have focused on becoming vertical plays spanning from seed to consumer-facing dispensaries, 1 Planet Pharma is a pure-play cannabis small business focused on a single point- supplying higher top quality hemp and cannabis derived components to customer brands. The upcoming launch of its Cannabis Futures system will present these brands with predictable pricing for constant, higher-top quality cannabis components that permit them to maintain their retail item supplying constant each in the deliverable and pricing.

“At its core, 1 Planet Pharma is not just a cannabis firm, we’re an components firm,” stated Chief Executive Officer Craig Ellins. “Cannabis is now a commodity just like coffee or soybeans. We’re not interested in competing with the massive players obtaining into branded cannabis merchandise. Alternatively, we want to provide and allow them. Our Cannabis Futures system will present important beverage providers, foods providers, cosmetic providers and any other enterprise searching to combine cannabis-primarily based components with their item supplying with a streamlined path to enter the cannabis market place.”

The Futures system will permit 1 Planet Pharma’s clients to commit to obtain a fixed quantity of hemp and cannabis derived components that will be grown and processed especially to their exclusive needs on land exclusively devoted to them. This will permit 1 Planet Pharma to give these clients a predetermined, constant cost for this future item. Buyers will be in a position to lock in steady pricing though 1 Planet Pharma will be in a position to extra accurately predict its personal recurring income and optimize its increasing operations.

In the future, 1 Planet Pharma believes that this model could lead to the improvement of a international cannabis commodities exchange. “We want to be aspect of making the lengthy-term international monetary and provide chain structures for the cannabis sector,” stated Ellins. “Partnership is a single of our core values and the foundation of our socially accountable practices. We think that robust infrastructure and systems will advantage the whole sector.”

1 Planet Pharma’s socially accountable partnerships with indigenous communities and nearby farmers in Colombia will give scalability to assistance its Cannabis Futures system and service the requires of big makers, though blending ancestral tactics with state-of-the-art technologies in a single of the most best cannabis-increasing places in the planet. 

Figure 1: 1 Planet Pharma to Launch Cannabis Futures Commoditization Plan in Colombia.

To view an enhanced version of Figure 1, please stop by:
https://orders.newsfilecorp.com/files/6276/49294_n2.jpg

Please note that from time to time the Business may perhaps post new data at its internet site: www.OneWorldPharma.com

1 Planet Pharma Business Make contact with:
Mimi Tekabe
1 Planet Pharma Inc.
1.800.605.3210
www.oneworldpharma.com

1 Planet Pharma Investor Relations &amp Monetary Media
Integrity Media

[email protected]
Toll Totally free: (888) 216-3595
www.IntegrityMedia.com

Facts about Forward-Seeking Statements

This press release consists of “forward-searching statements” that incorporate data relating to future events. Forward-searching statements really should not be study as a assure of future functionality or final results and will not necessarily be correct indications of the instances at, or by, which that functionality or these final results will be accomplished. Forward-searching statements are primarily based on data readily available at the time they are produced and/or management’s great faith belief as of that time with respect to future events and are topic to dangers and uncertainties that could lead to actual functionality or final results to differ materially from these expressed in, or recommended by, the forward-searching statements. Critical components that could lead to these variations incorporate, but are not restricted to: the Company’s require for added funding, the demand for the Company’s merchandise, governmental regulation of the cannabis sector, the Company’s potential to keep consumer and strategic small business relationships, the effect of competitive merchandise and pricing, dangers connected to operating in Colombia, development in targeted markets, the adequacy of the Company’s liquidity and monetary strength to assistance its development, and other dangers that may perhaps be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a extra detailed description of the danger components and uncertainties affecting 1 Planet Pharma, please refer to the Company’s Present Report on eight-KA filed with the Securities and Exchange Commission on July 12, 2019, which is readily available at www.sec.gov. The Business undertakes no obligation to publicly update or revise any forward-searching statements, no matter whether as a outcome of new data, future events, or otherwise.

To view the supply version of this press release, please stop by https://www.newsfilecorp.com/release/49294

[ad_2]

Latest posts